Biocryst Pharmaceuticals Inc. (NASDAQ:BCRX) traded at $4.16 at close of the session on Friday, April 26, remained unchanged from its previous day’s price.
Looking at the stock we see that its previous close was $4.16 . In terms of its 52-week price range, BCRX has a high of $9.06 and a low of $4.03. The company’s stock has lost about -19.22% over that past 30 days.
Biocryst Pharmaceuticals Inc. has a market cap of $857.58 million. Estimates by analysts give the company expected earnings per share (EPS) of -$0.21, with the EPS growth for the year raised at -$0.63 for 2024 and -$0.35 for next year. These figures represent 46.60% and 44.40% growth in EPS for the two years respectively.
Analysts tracking the company’s growth have also given it a consensus growth in revenue estimated at $85.6 million, with a low of $83.53 million and a high of $87.41 million. The median projection represents growth squeezing down to 24.50% compared to sales growth for the corresponding quarter a year ago. According to analyst consensus estimates figures, the company’s yearly revenue forecast for 2024 is expected to hit $394.54 million, or 19.00% up from figures reported last year.
On the other hand, looking at the outlook for the BCRX stock, short term indicators assign the stock an average of 100% Sell, while medium term indicators assign it an average of 100% Sell. Long term indicators on average place the stock in the category of 100% Sell.
Looking further, we note the current price level is -10.39% off its SMA20 and -18.53% from its 50-day simple moving average. The RSI (14) is pointing at 30.08 while the volatility over the past week is 4.58% and jumps to 5.29% over the past one month. The beta value is 1.96, while the average true range (ATR) is currently pointing at 0.25.
Coming back to Biocryst Pharmaceuticals Inc. (NASDAQ:BCRX), we note that the average 3-month trading volume was 3.17 million. Current shares outstanding are 205.77 million.
The insiders hold 3.68% of the company’s shares while institutions hold 84.17%. Investors should be excited about this stock as its upside potential is great, with current price pushing the stock -30.55% down in year-to-date price movement.
